Literature DB >> 33407952

Circ_0000396 inhibits rheumatoid arthritis synovial fibroblast growth and inflammatory response via miR-203/HBP1 axis.

Laifang Wang1, Qing Zhao1, Na Wang1, Yanjie Ding2, Lingli Kong1, Jing Wang1.   

Abstract

BACKGROUND: Circ_0000396 was found to be down-regulated in the rheumatoid arthritis (RA) patients and had a high diagnostic value. However, the function and mechanisms underlying circ_0000396 in RA progression remain unclear.
METHODS: The expression of circ_0000396, microRNA (miR)-203 and HMG-box transcription factor 1 (HBP1) was detected using qRT-PCR and western blot. The proliferative and apoptotic capabilities of rheumatoid arthritis synovial fibroblasts (RASFs) were measured by colony formation, CCK-8, flow cytometry and western blot assays, respectively. The levels of interleukins (IL)-6, IL-1β, IL-8 and tumor necrosis factor-α (TNF-α) were detected using enzyme-linked immunosorbent assay (ELISA). The target correlations between miR-203 and circ_0000396 or HBP1 were validated using pull-down and dual-luciferase reporter assay.
RESULTS: Circ_0000396 was decreased in RA synovial tissues and RASFs, and overexpression of circ_0000396 suppressed cell proliferation, induced cell apoptosis and reduced the release of inflammatory cytokine IL-6, IL-1β, IL-8 and TNF-α in RASFs, while circ_0000396 deletion functioned oppositely. MiR-203 was confirmed to be a target of circ_0000396, and miR-203 reversed the protective effects of circ_0000396 on the dysfunction and inflammation of RASFs. HBP1 was a target of miR-203, and silencing miR-203 inhibited RASFs malignant changes by regulating HBP1. In addition, circ_0000396 could regulate HBP1 by sponging miR-203, and HBP1 decrease attenuated the effects of circ_0000396 on RASF growth and inflammation.
CONCLUSION: Circ_0000396 inhibited the growth and inflammation in RASFs by regulating miR-203/HBP1 axis, providing a potential therapeutic target for RA.

Entities:  

Keywords:  Rheumatoid arthritis; Synovial fibroblasts; circ_0000396; miR-203; HBP1

Year:  2021        PMID: 33407952     DOI: 10.1186/s40709-020-00131-4

Source DB:  PubMed          Journal:  J Biol Res (Thessalon)        ISSN: 1790-045X            Impact factor:   1.889


  5 in total

1.  MiR-20a regulates fibroblast-like synoviocyte proliferation and apoptosis in rheumatoid arthritis.

Authors:  X-J Wei; X-W Li; J-L Lu; Z-X Long; J-Q Liang; S-B Wei; C-X Lu; W-Z Lu
Journal:  Eur Rev Med Pharmacol Sci       Date:  2020-07       Impact factor: 3.507

Review 2.  [Rheumatoid arthritis and cytokines].

Authors:  Shunta Kaneko; Yuya Kondo; Masahiro Yokosawa; Takayuki Sumida
Journal:  Nihon Rinsho       Date:  2016-06

3.  Epidemiology, pathophysiology, and diagnosis of rheumatoid arthritis: A Synopsis.

Authors:  Allan Gibofsky
Journal:  Am J Manag Care       Date:  2014-05       Impact factor: 2.229

4.  Hsa_circ_0001859 Regulates ATF2 Expression by Functioning as an MiR-204/211 Sponge in Human Rheumatoid Arthritis.

Authors:  Bingrui Li; Nianyu Li; Le Zhang; Kai Li; Yingtian Xie; Meilan Xue; Zheng Zheng
Journal:  J Immunol Res       Date:  2018-01-17       Impact factor: 4.818

Review 5.  Fibroblasts as therapeutic targets in rheumatoid arthritis and cancer.

Authors:  Maria Juarez; Andrew Filer; Christopher D Buckley
Journal:  Swiss Med Wkly       Date:  2012-02-24       Impact factor: 2.193

  5 in total
  3 in total

Review 1.  Promising Therapeutic Targets for Treatment of Rheumatoid Arthritis.

Authors:  Jie Huang; Xuekun Fu; Xinxin Chen; Zheng Li; Yuhong Huang; Chao Liang
Journal:  Front Immunol       Date:  2021-07-09       Impact factor: 7.561

2.  Circ_0001947 promotes cell proliferation, invasion, migration and inflammation and inhibits apoptosis in human rheumatoid arthritis fibroblast-like synoviocytes through miR-671-5p/STAT3 axis.

Authors:  Yang Yang; Shudian Lin; Zhou Yang; Yanyan Huang; Feng Zhan
Journal:  J Orthop Surg Res       Date:  2022-01-29       Impact factor: 2.359

3.  Metabonomic analysis of abnormal sphingolipid metabolism in rheumatoid arthritis synovial fibroblasts in hypoxia microenvironment and intervention of geniposide.

Authors:  Jiang-Tao Ke; Heng Zhang; Yan-Hong Bu; Pei-Rong Gan; Fang-Yuan Chen; Xin-Tong Dong; Yan Wang; Hong Wu
Journal:  Front Pharmacol       Date:  2022-07-22       Impact factor: 5.988

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.